The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 13, 2012

Filed:

Oct. 17, 2008
Applicants:

Alessio Moriconi, L'Aquila AQ, IT;

Andrea Aramini, L'Aquila AQ, IT;

Inventors:

Alessio Moriconi, L'Aquila AQ, IT;

Andrea Aramini, L'Aquila AQ, IT;

Assignee:

Dompe S.p.A, , IT;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4174 (2006.01); A61K 31/422 (2006.01); A61K 31/427 (2006.01); C07D 233/88 (2006.01); C07D 263/48 (2006.01); C07D 277/38 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a novel class of (R)-4-(heteroaryl)phenylpropionic derivatives of formula (I), useful in the inhibition of the chemotactic activation induced by the fraction C5a of complement. Said compounds are useful in the treatment of pathologies depending on the chemotactic activation of neutrophils and monocytes induced by the fraction C5a of the complement. In particular, the compounds of the invention are useful in the treatment of autoimmune hemolytic anemia (AIHA), psoriasis, bullous pemphigoid, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, idiopathic fibrosis, glomerulonephritis and in the prevention and treatment of injury caused by ischemia and reperfusion.


Find Patent Forward Citations

Loading…